[1]
2023. Efficacy and Safety of Intravenous Ferric Carboxymaltose In Patients with Chronic Heart Failure and Associated Iron Deficiency: Insights from a Tertiary Care Research Institute In India. Cardiology and Cardiovascular Medicine. 7, 3 (Jun. 2023), 158–161.